Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Agnosia × Botulinum Toxins, Type A × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Breast Diseases 2 Wounds and Injuries 1 Stroke 1 Stomach Neoplasms 1 Spinal Cord Injuries 1 Skin Diseases 1 Rectal Neoplasms 1 Prostatic Hyperplasia 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Neoplasms by Site 1 Muscular Atrophy 1 Muscle Spasticity 1 Lower Urinary Tract Symptoms 1 Low Anterior Resection Syndrome 1 Head and Neck Neoplasms 1 Gastroparesis 1 Ganglion Cysts 1 Esophageal Neoplasms 1 Esophageal Motility Disorders 1 Esophageal Diseases 1 Esophageal Achalasia 1 Cluster Headache 1 Brain Injuries 1 Agnosia 1

Interventions

Bupivacaine 9 Ketamine 8 Ropivacaine 6 Fentanyl 6 Dexmedetomidine 6 Anesthesia, General 6 Acetaminophen 6 Morphine 5 Lidocaine 5 Analgesics, Opioid 5 Acupuncture Therapy 5 Pregabalin 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Tramadol 3 Sodium Chloride 3 Saline Solution 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Surveys and Questionnaires 2 Radiofrequency Ablation 2 Magnesium Sulfate 2 Levobupivacaine 2 Injections, Epidural 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06807164 2026-03-17

SerCaBot

Centre Oscar Lambret

Phase 2 Recruiting

Agnosia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡